Lowe Amanda, Hamilton Michael, Greenall BScPhm MHSc Julie, Ma Jessica, Dhalla Irfan, Persaud Nav
Office of the Chief Coroner for Ontario (Lowe), Toronto, Ont.; Institute for Safe Medication Practices Canada (Hamilton, Greenall, Ma); St. Michael's Hospital, Health Quality Ontario and Department of Medicine and Institute for Health Policy, Management and Evaluation, University of Toronto (Dhalla); Department of Family and Community Medicine, St. Michael's Hospital, and Department of Family and Community Medicine, University of Toronto (Persaud), Toronto, Ont.
CMAJ Open. 2017 Mar 2;5(1):E184-E189. doi: 10.9778/cmajo.20160013. eCollection 2017 Jan-Mar.
Opioids have narrow therapeutic windows, and errors in ordering or administration can be fatal. The purpose of this study was to describe deaths involving hydromorphone and morphine, which have similar-sounding names, but different potencies.
In this case series, we describe deaths of patients admitted to hospital or residents of long-term care facilities that involved hydromorphone and morphine. We searched for deaths referred to the Patient Safety Review Committee of the Office of the Chief Coroner for Ontario between 2007 and 2012, and subsequently reviewed by 2014. We reviewed each case to identify intervention points where errors could have been prevented.
We identified 8 cases involving decedents aged 19 to 91 years. The cases involved errors in prescribing, order processing and transcription, dispensing, administration and monitoring. For 7 of the 8 cases, there were multiple (2 or more) possible intervention points. Six cases may have been prevented by additional patient monitoring, and 5 cases involved dispensing errors.
Opioid toxicity deaths in patients living in institutions can be prevented at multiple points in the prescribing and dispensing processes. Interventions aimed at preventing errors in hydromorphone and morphine prescribing, administration and patient monitoring should be implemented and rigorously evaluated.
阿片类药物的治疗窗较窄,开方或给药错误可能致命。本研究旨在描述涉及氢吗啡酮和吗啡的死亡案例,这两种药物名称相似,但效力不同。
在这个病例系列中,我们描述了入住医院的患者或长期护理机构居民中涉及氢吗啡酮和吗啡的死亡情况。我们搜索了2007年至2012年间提交给安大略省首席验尸官办公室患者安全审查委员会的死亡案例,并于2014年进行了后续审查。我们审查了每个案例,以确定本可预防错误的干预点。
我们确定了8例涉及19至91岁死者的案例。这些案例涉及处方、医嘱处理与转录、配药、给药和监测方面的错误。在这8例案例中的7例中,存在多个(2个或更多)可能的干预点。6例本可通过加强患者监测来预防,5例涉及配药错误。
机构内患者的阿片类药物中毒死亡可在处方和配药过程中的多个环节预防。应实施并严格评估旨在预防氢吗啡酮和吗啡处方、给药及患者监测错误的干预措施。